Hemofiltration and Hemodiafiltration for End-Stage Renal Disease

Chronic Kidney Disease, Dialysis, & Transplantation

Volumn , Issue , 2005, Pages 481-490

  Huang, Zhongping ^a   Gao, Dayong ^a   Henderson, Lee W ^b   Clark, William R ^c  

^a UNIVERSITY OF KENTUCKY   (United States)

^b BAXTER HEALTHCARE CORPORATION   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882864327     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-0158-4.50028-8     Document Type: Chapter

References (84)

1. Clark WR, Hamburger RJ, Lysaght MJ Effect of membrane composition and structure on performance and biocompatibility in hemodialysis. Kidney Int 1999, 56:2005-2015.
2. Henderson LW The problem of peritoneal membrane area and permeability. Kidney Int 1973, 3:409-410.
3. Clark WR, Macias WL, Molitoris BA, Wang NHL Plasma protein adsorption to highly permeable hemodialysis membranes. Kidney Int 1995, 48:481-487.
4. Vanholder R, De Smet R, Glorieux G, et al. European Uremic Toxin Work Group (EUTox): Review on uremic toxins: Classification, concentration, and interindividual variability. Kidney Int 2003, 63:1934-1943.
5. Lowrie EG, Steinberg SM, Galen MA, et al. Factors in the dialysis regimen which contribute to alternations in the abnormalities of uremia. Kidney Int 1976, 10:409-422.
6. Lowrie EG, Laird NM, Parker TF, Sargent JA Effect of the hemodialysis prescription on patient morbidity: Report from the National Cooperative Dialysis Study. N Engl J Med 1981, 305:1176-1181.
7. Gotch FA, Sargent JA A mechanistic analysis of the National Cooperative Dialysis Study. Kidney Int 1985, 28:526-534.
8. Owen WF, Lew NL, Liu Y, et al. The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 1993, 329:1001-1006.
9. Parker TF, Husni L, Huang W, et al. Survival of hemodialysis patients in the United States is improved with a greater quantity of dialysis. Am J Kidney Dis 1994, 23:67-680.
10. Collins AJ, Ma JZ, Umen A, Keshaviah P Urea index and other predictors of hemodialysis survival. Am J Kidney Dis 1994, 23:272-282.
11. Hakim RM, Breyer J, Ismail N, Schulman G Effects of dose of dialysis on morbidity and mortality. Am J Kidney Dis 1994, 23:661-669.
12. Peritoneal Dialysis Study Group: Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcomes. J Am Soc Nephrol 1996, 7:198-207. CANADA-USA (CANUSA).
13. Teehan B, Schleifer C, Brown J, et al. Urea kinetic analysis and clinical outcomes on CAPD: A five year longitudinal study. Adv Perit Dial 1990, 6:181-185.
14. Genestier S, Hedelin G, Schaffer P, Faller B Prognostic factors in CAPD patients: A retrospective study of a 10-year period. Nephrol Dial Transplant 1995, 10:1905-1911.
15. Update 2000. Am J Kidney Dis 2001, 37(suppl 1):S7-S64. NKF-DOQI Clinical Practice Guidelines for Hemodialysis Adequacy.
16. Update 2000. Am J Kidney Dis 2001, 37(suppl 1):S65-S136. NKF-DOQI Clinical Practice Guidelines for Peritoneal Dialysis Adequacy.
17. Eknoyan G, Beck GJ, Cheung AK, et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 2002, 347:2010-2019.
18. Paniagua R, Amato D, Vonesh EF, et al. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 2002, 13:1307-1320.
19. Clark WR, Winchester JW: Middle molecules and small molecular weight proteins in ESRD: Properties and strategies for their removal. Adv Renal Replace Ther (in press).
20. Diaz-Buxo J Continuous flow peritoneal dialysis: Clinical applications. Blood Purif 2002, 20:36-39.
21. Ting G The strategic role of daily hemodialysis in managed care in the United States. Semin Dial 2000, 13:385-388.
22. Pierratos A Nocturnal home haemodialysis: An update on a 5-year experience. Nephrol Dial Transplant 1999, 14:2835-2840.
23. Heidenheim AP, Muirhead N, Moist L, Lindsay RM Patient quality of life on quotidian hemodialysis. Am J Kidney Dis 2003, 42(suppl 1):36-41.
24. Morena MD, Guo D, Balakrishnan VS, et al. Effect of a novel adsorbent on cytokine responsiveness to uremic plasma. Kidney Int 2003, 63:1150-1154.
25. Henderson LW Biophysics of ultrafiltration and hemofiltration. Replacement of Renal Function by Dialysis 1996, 114-118. Kluwer Academic Publishers, Dortdrecht. 4th ed. C. Jacobs (Ed.).
26. Rockel A, Hertel J, Fiegel P, et al. Permeability and secondary membrane formation of a high flux polysulfone hemofilter. Kidney Int 1986, 30:429-432.
27. Kim S Characteristics of protein removal in hemodiafiltration. Contrib Nephrol 1994, 108:23-37.
28. Ofsthun NJ, Zydney AL Importance of convection in artificial kidney treatment. Contrib Nephrol 1994, 108:53-70.
29. Bosch T, Schmidt B, Samtleben W, Gurland H Effect of protein adsorption on diffusive and convective transport through polysulfone membranes. Contrib Nephrol 1985, 46:14-22.
30. Langsdorf LJ, Zydney AL Effect of blood contact on the transport properties of hemodialysis membranes: A two-layer model. Blood Purif 1994, 12:292-307.
31. Morti SM, Zydney AL Protein-membrane interactions during hemodialysis: Effects on solute transport. ASAIO J 1998, 44:319-326.
32. Henderson LW Pre vs post dilution hemofiltration. Clin Nephrol 1979, 11:120-124.
33. Clark WR, Gao D Low-molecular weight proteins in end-stage renal disease: Potential toxicity and dialytic removal mechanisms. J Am Soc Nephrol 2002, 13:S41-S47.
34. Clark WR, Gao D Properties of membranes used for hemodialysis therapy. Semin Dial 2002, 15:1-5.
35. Werynski A, Waniewski J Theoretical description of mass transport in medical membrane devices. Artif Organs 1995, 19:420-427.
36. Silverstein ME, Ford CA, Lysaght MJ, Henderson LW Treatment of severe fluid overload by ultrafiltration. N Engl J Med 1974, 291:747-751.
37. Henderson LW, Colton CK, Ford CA, Lysaght MJ Kinetics of hemodiafiltration. II. Clinical characterization of a new blood cleansing modality. J Lab Clin Med 1975, 85:372-391.
38. Colton CK, Henderson LW, Ford C, Lysaght MJ Kinetics of hemodiafiltration. I. In vitro transport characteristics of a hollow-fiber blood ultrafilter. J Lab Clin Med 1975, 85:355-371.
39. Clark WR, Gao D: Determinants of small solute clearance in hemodialysis. Semin Dial (in press).
40. Maack T, Johnson V, Kau ST, et al. Renal filtration, transport, and metabolism of low-molecular weight proteins: A review. Kidney Int 1979, 16:251-270.
41. Quellhorst E New trends in blood purification. Life Support Syst 1983, 1:207-216.
42. Quellhorst E, Scheunemann B, Hildebrand U Hemofiltration: An improved method of treatment for chronic renal failure. Contrib Nephrol 1985, 44:194-211.
43. Baldamus CA, Quellhorst E Outcome of long-term hemofiltration. Kidney Int 1985, 17(suppl):S41-S46.
44. Henderson LW, Beans E Successful production of sterile pyrogen-free electrolyte solution by ultrafiltration. Kidney Int 1978, 14:522-525.
45. Shaldon S, Beau MC, Deschodt G, et al. Economic preparation of sterile non-pyrogenic infusate for hemofiltration. Dial Transplant 1983, 12:792-793.
46. Canaud B, Nguyen QV, Lagrarde C, et al. Clinical evaluation of a multipurpose dialysis system adequate for hemodialysis or for post-dilution hemofiltration/hemodiafiltration with on-line preparation of substitution fluid from dialysate. Contrib Nephrol 1985, 46:184-186.
47. Ledebo I Principles and practice of hemofiltration and hemodiafiltration. Artif Organs 1998, 22:20-25.
48. Ofsthun NJ, Colton CK, Lysaght MJ Determinants of fluid and solute removal rates during hemofiltration. Hemofiltration 1986, 18-39. Springer-Verlag, Berlin. L.W. Henderson, E.A. Quellhorst, C.A. Baldamus, M.J. Lysaght (Eds.).
49. Leber HW, Wizemann V, Goubeaud G, et al. Simultaneous hemofiltration/hemodialysis: An effective alternative to hemofiltration and conventional hemodialysis in the treatment of uremic patients. Clin Nephrol 1978, 9:115-121.
50. Kunitomo T, Kirkwood RG, Kumazawa S, et al. Clinical evaluation of postdilution dialysis with a combined ultrafiltration (UF)?hemodialysis (HD) system. Trans Am Soc Artif Intern Organs 1978, 24:169-177.
51. Ledebo I On-line hemodiafiltration: Technique and therapy. Adv Renal Replace Ther 1999, 6:195-208.
52. Maduell F, del Pozo C, Garcia H, et al. Change from conventional hemodiafiltration to on-line hemodiafiltration. Nephrol Dial Transplant 1999, 14:1202-1207.
53. Canaud B, Bosc JY, Leray-Moragues H, et al. On-line hemodiafiltration: Safety and efficacy in long-term clinical practice. Nephrol Dial Transplant 2000, 15(suppl 1):60-67.
54. Wizemann V, Lotz C, Techert F, Uthoff S On-line hemodiafiltration vs. low-flux haemodialysis: A prospective, randomized study. Nephrol Dial Transplant 2000, 15(suppl 1):43-48.
55. Ono M, Taoka M, Takagi T, et al. Comparison of types of on-line hemodiafiltration from the standpoint of low-molecular weight protein removal. Contrib Nephrol 1994, 108:38-45.
56. Ahrenholz P, Winkler RE, Ramlow W, et al. On-line hemodiafiltration with pre- and post-dilution: A comparison of efficacy. Int J Artif Organs 1997, 20:81-90.
57. Altieri P, Sorba GB, Bolasco PG, et al. On-line predilution hemofiltration versus ultrapure high-flux hemodialysis: A multi-center prospective study in 23 patients. Blood Purif 1997, 15:169-181.
58. Altieri P, Sorba G, Bolasco P, et al. Pre-dilution haemofiltration?the Sardinian studies: Present and future. Nephrol Dial Transplant 2000, 15(suppl 2):55-59.
59. Bolasco P, Altieri P, Sorba G, et al. Adequacy in pre-dilution haemofiltration: Kt/V or infusion volume?. Nephrol Dial Transplant 2000, 15(suppl 2):60-64.
60. Altieri P, Sorba G, Bolasco P, et al. Predilution haemofiltration? the Second Sardinian Multicentre Study: Comparisons between haemofiltration and haemodialysis during identical Kt/V and session times in a long-term cross-over study. Nephrol Dial Transplant 2001, 16:1207-1213.
61. Anderstam B, Mamoun A, Sodersten P, Bergstrom J Middle-sized molecule fractions isolated from uremic ultrafiltrate and normal urine inhibit ingestive behavior in the rat. J Am Soc Nephrol 1996, 7:2453-2460.
62. Lin CL, Yang CW, Chiang CC, et al. Long-term on-line hemodiafiltration reduces predialysis beta-2-microglobulin levels in chronic hemodialysis patients. Blood Purif 2001, 19:301-307.
63. Ward RA, Schmidt B, Hullin J, et al. A comparison of on-line hemodiafiltration and high-flux hemodialysis: A prospective clinical study. J Am Soc Nephrol 2000, 11:2344-2350.
64. Ofsthun NJ, Leypoldt JK Ultrafiltration and backfiltration during hemodialysis. Artif Organs 1995, 19:1143-1161.
65. Lonneman G Dialysate bacteriological quality and the permeability of dialyzer membranes to pyrogens. Kidney Int 1993, (suppl 41):S195-S200.
66. Clark WR, Leypoldt JK, Henderson LW, et al. Quantifying the effect of changes in the hemodialysis prescription on effective solute removal with a mathematical model. J Am Soc Nephrol 1999, 10:601-610.
67. Clark WR, Henderson LW Renal vs continuous vs intermittent therapies for removal of uremic toxins. Kidney Int 2001, 59(suppl 78):S298-S303.
68. Fagugli RM, Reboldi G, Quintaliani G, et al. Short daily hemodialysis: Blood pressure control and left ventricular mass reduction in hypertensive hemodialysis patients. Am J Kidney Dis 2001, 38:371-376.
69. Galland R, Traeger J, Arkouche W, et al. Short daily hemodialysis and nutritional status. Am J Kidney Dis 2001, 37(1 suppl 2):S95-S98.
70. Pierratos A Nocturnal home haemodialysis: An update on a 5-year experience. Nephrol Dial Transplant 1999, 14:2835-2840.
71. Raj DS, Charra B, Pierratos A, Work J In search of ideal hemodialysis: Is prolonged frequent dialysis the answer?. Am J Kidney Dis 1999, 34:597-610.
72. Depner TA Benefits of more frequent dialysis: Lower TAC at the same Kt/V. Nephrol Dial Transplant 1998, 13(suppl 6):20-24.
73. Ledebo I Does convective therapy applied daily approach renal blood purification?. Kidney Int 2001, 59(suppl 78):S286-S291.
74. Canaud B, Assounga A, Kerr P, et al. Failure of a daily haemofiltration programme using a highly permeable membrane to return β2-microglobulin concentrations to normal in haemodialysis patients. Nephrol Dial Transplant 1992, 7:924-939.
75. Maduell F, Navarro V, Torregrosa E, et al. Change from three times a week on-line hemodiafiltration to short daily on-line hemodiafiltration. Kidney Int 2003, 64:305-313.
76. Casino FG, Lopez T The equivalent renal urea clearance: A new parameter to assess dialysis dose. Nephrol Dial Transplant 1996, 11:1574-1591.
77. Gotch FA The current place of urea kinetic modeling with respect to different dialysis modalities. Nephrol Dial Transplant 1998, 13(suppl 6):10-14.
78. Zimmerman DL, Swedko PJ, Posen GA, Burns KD Daily hemofiltration with a simplified method of delivery. ASAIO J 2003, 49:426-429.
79. Shaldon S, Beau MC, Deschodt G, Mion C Mixed hemofiltration: 18 months experience with ultrashort treatment time. Trans Am Soc Artif Organs 1981, 27:610-612.
80. TM MD 190 diafilter versus post-dilution HDF (Abstract). J Am Soc Nephrol 2003, 14:501A.
81. Hillion D, Haas T, Pertuiset N, Uzan M Pre-postdilution hemofiltration. Blood Purif 1995, 13:241-245.
82. Pedrini LA, de Christofaro V, Pagliari B, Sama F Mixed pre-dilution and post-dilution online hemodiafiltration compared with traditional infusion modes. Kidney Int 2000, 58:2155-2165.
83. Santoro A, Canova C, Mancini E, et al: Protein loss in on-line hemofiltration. Blood Purif (in press).
84. Shinzato T, Miwa M, Nakai S, et al. Alternate repetition of short fore- and backfiltrations reduces convective albumin loss. Kidney Int 1996, 50:432-435.